Combinational Administration of Mesenchymal Stem Cell-Derived Exosomes and Metformin Reduces Inflammatory Responses in an In Vitro Model of Insulin Resistance in HepG2 Cells

Researchers investigated the anti-inflammatory effect of Wharton’s jelly MSCs derived exosomes in combination with metformin in the HepG2 cells insulin resistance model induced by high glucose.